Evidence map›Paper›PMID 36013020›Full record

ArticleJournal of clinical medicine2022

Comparison of the 2013 and 2019 Nationwide Surveys on the Management of Chronic Kidney Disease by General Practitioners in Japan.

Satoru Tatematsu, Kazuo Kobayashi, Yasunori Utsunomiya, Tsuguru Hatta, Taisuke Isozaki, Masanobu Miyazaki, Yosuke Nakayama, Takuo Kusumoto, Nobuo Hatori, Haruhisa Otani

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Observational
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Satoru TatematsuCommittee of Kidney and Electrolyte Disease, Japan Physicians Association, Tokyo 101-0062, Japan.ORCID 0000-0003-2260-7121
Kazuo KobayashiCommittee of Kidney and Electrolyte Disease, Japan Physicians Association, Tokyo 101-0062, Japan.ORCID 0000-0002-1284-9728
Yasunori UtsunomiyaCommittee of Kidney and Electrolyte Disease, Japan Physicians Association, Tokyo 101-0062, Japan.ORCID 0000-0002-4959-3076
Tsuguru HattaCommittee of Kidney and Electrolyte Disease, Japan Physicians Association, Tokyo 101-0062, Japan.
Taisuke IsozakiCommittee of Kidney and Electrolyte Disease, Japan Physicians Association, Tokyo 101-0062, Japan.
Masanobu MiyazakiCommittee of Kidney and Electrolyte Disease, Japan Physicians Association, Tokyo 101-0062, Japan.
Yosuke NakayamaCommittee of Kidney and Electrolyte Disease, Japan Physicians Association, Tokyo 101-0062, Japan.
Takuo KusumotoCommittee of Kidney and Electrolyte Disease, Japan Physicians Association, Tokyo 101-0062, Japan.
Nobuo HatoriKobayashi Hospital, Odawara 250-0011, Japan.
Haruhisa OtaniCommittee of Kidney and Electrolyte Disease, Japan Physicians Association, Tokyo 101-0062, Japan.
Japan Medical Association · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2019, the Japan Physicians Association conducted a second nationwide survey on the management of chronic kidney disease (CKD) among the Japanese general practitioners (GPs). We aimed to clarify the changes in the state of CKD medical care by GPs since the 2013 survey. The 2013 and 2019 surveys included 2214 and 601 GPs, respectively, who voluntarily participated. The two surveys were compared, using propensity score matching to balance the background of the responded GPs. For the medical care of CKD, the frequency of urine or blood examination, use of estimated glomerular filtration rate (eGFR) value for CKD management, and continuous use of renin-angiotensin system inhibitors for their reno-protective effects were significantly higher in 2019 than in 2013 (all: p < 0.001). The medical cooperation in CKD management, the utilization of the clinical path for CKD management and the measurement of the eGFR during the medical health checkup were significantly increased in 2019, compared to those in 2013. More GPs felt dissatisfied with the components of CKD treatment by nephrologists (p < 0.001). The two surveys confirmed improvements in the level of medical care for CKD and a strengthening in cooperation. However, the dissatisfaction with the consultation with nephrologists did not necessarily improve.

Indexed as

chronic kidney diseasegeneral practitionerguidelinesquestionnairesurvey

Identifiers

PMID36013020
PMCPMC9410076
OpenAlexW4292295134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.